Scott F Sones

US Patent:

20080292693, Nov 27, 2008

Filed:

May 21, 2007

Appl. No.:

11/751562

Inventors:

Scott F. Sones - Niland CA, US

International Classification:

A61K 36/752
A61K 9/48
A61P 1/00

US Classification:

424456, 424736

Abstract:

The present disclosure provides for a novel composition, with active ingredients comprising d-Limonene and Aloe mucilaginous polysaccharides (AMPs), for the treatment of a wide variety of digestive system disorders and diseases, including conditions which affect the stomach, esophagus, bowel, colon, liver or pancreas are considered digestive system diseases and disorders, including, but not limited to, gastro-esophagus reflux disease (GERD), digestive problems such as acid reflux disease, Crohn's disease, colitis, inflammatory bowel disease (IBD), irritable bowel disease (IBS), diverticulitis, gastritis, peptic ulcers and spastic colon.

US Patent:

20080166420, Jul 10, 2008

Filed:

Jul 30, 2007

Appl. No.:

11/830749

Inventors:

Scott F. Sones - Niland CA, US

International Classification:

A61K 35/60

US Classification:

424523

Abstract:

The present disclosure provides for novel krill oil-based compositions, method of administration and method of manufacture which provide for the treatment and prevention of cardiovascular disease, including the reduction of one or more significant risk factors involved with cardiovascular disease. The active ingredients of the composition include krill oil, combined in one embodiment with niacin, and combined in an alternate embodiment with polymethoxylated flavones (PMFs), and combined in yet another embodiment with , and combined in a further embodiment with

US Patent:

20080166418, Jul 10, 2008

Filed:

Apr 4, 2007

Appl. No.:

11/696479

Inventors:

Scott F. Sones - Niland CA, US

International Classification:

A61K 35/56
A61K 31/20
A61K 31/455

US Classification:

424522, 514275, 514356, 514415, 514422, 514456, 514460

Abstract:

The present disclosure provides for novel krill oil-based compositions, method of administration and method of manufacture which provide for the treatment and prevention of cardiovascular disease, including the reduction of one or more significant risk factors involved with cardiovascular disease. The active ingredients of the composition include krill oil, combined in one embodiment with niacin, and combined in an alternate embodiment, polymethoxylated flavones (PMFs).

US Patent:

20080166419, Jul 10, 2008

Filed:

May 9, 2007

Appl. No.:

11/803050

Inventors:

Scott F. Sones - Niland CA, US

International Classification:

A61K 35/60

US Classification:

424523

Abstract:

The present disclosure provides for novel krill oil-based compositions, method of administration and method of manufacture which provide for the treatment and prevention of cardiovascular disease, including the reduction of one or more significant risk factors involved with cardiovascular disease. The active ingredients of the composition include krill oil, combined in one embodiment with niacin, and combined in an alternate embodiment with polymethoxylated flavones (PMFs), and combined in yet another embodiment with